The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review

Background: Schizophrenia is a severe mental disorder characterized by positive, negative, affective, and cognitive symptoms. Affective symptoms in patients with schizophrenia have traditionally been overlooked or even neglected because they are not considered as fundamental as positive and negative...

Full description

Bibliographic Details
Main Authors: Andrea Fiorillo, Gaia Sampogna, Umberto Albert, Emi Bondi, Serafino De Giorgi, Andrea Fagiolini, Maurizio Pompili, Gianluca Serafini, Umberto Volpe, Antonio Vita
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/14/3/225
_version_ 1797241776100081664
author Andrea Fiorillo
Gaia Sampogna
Umberto Albert
Emi Bondi
Serafino De Giorgi
Andrea Fagiolini
Maurizio Pompili
Gianluca Serafini
Umberto Volpe
Antonio Vita
author_facet Andrea Fiorillo
Gaia Sampogna
Umberto Albert
Emi Bondi
Serafino De Giorgi
Andrea Fagiolini
Maurizio Pompili
Gianluca Serafini
Umberto Volpe
Antonio Vita
author_sort Andrea Fiorillo
collection DOAJ
description Background: Schizophrenia is a severe mental disorder characterized by positive, negative, affective, and cognitive symptoms. Affective symptoms in patients with schizophrenia have traditionally been overlooked or even neglected because they are not considered as fundamental as positive and negative symptoms in the choice of medication. Methods: This paper aims to systematically evaluate the efficacy and safety of lurasidone in the treatment of depressive symptoms of schizophrenia. Results: Lurasidone appears to be particularly effective on the depressive symptomatology of schizophrenia while also alleviating the positive and negative symptoms associated with the illness. Conclusions: The efficacy of lurasidone in treating patients with first-episode psychosis who present with predominant depressive symptoms suggests that this medication may be a valuable treatment option not only for established cases of schizophrenia but also for individuals in the early stages of the illness. The good tolerability of lurasidone is an important factor that may positively influence treatment decisions.
first_indexed 2024-04-24T18:28:42Z
format Article
id doaj.art-112bb0c3ac2240bd8d831f8bd64b8de3
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-04-24T18:28:42Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-112bb0c3ac2240bd8d831f8bd64b8de32024-03-27T13:28:41ZengMDPI AGBrain Sciences2076-34252024-02-0114322510.3390/brainsci14030225The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A ReviewAndrea Fiorillo0Gaia Sampogna1Umberto Albert2Emi Bondi3Serafino De Giorgi4Andrea Fagiolini5Maurizio Pompili6Gianluca Serafini7Umberto Volpe8Antonio Vita9Department of Psychiatry, University of Campania “L. Vanvitelli”, 80138 Naples, ItalyDepartment of Psychiatry, University of Campania “L. Vanvitelli”, 80138 Naples, ItalyDepartment of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, ItalyDepartment of Mental Health and Addictions, ASST Papa Giovanni XXIII, 24121 Bergamo, ItalyDepartment of Mental Health, ASL Lecce, 73100 Lecce, ItalyDivision of Psychiatry, University of Siena, 53100 Siena, ItalyDepartment of Neurosciences, Mental Health and Sensory Organs, Sant’Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035, 00189 Rome, ItalySection of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, 16131 Genoa, ItalyClinical Psychiatry Unit, Department of Clinical Neurosciences, Università Politecnica delle Marche, 60126 Ancona, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, ItalyBackground: Schizophrenia is a severe mental disorder characterized by positive, negative, affective, and cognitive symptoms. Affective symptoms in patients with schizophrenia have traditionally been overlooked or even neglected because they are not considered as fundamental as positive and negative symptoms in the choice of medication. Methods: This paper aims to systematically evaluate the efficacy and safety of lurasidone in the treatment of depressive symptoms of schizophrenia. Results: Lurasidone appears to be particularly effective on the depressive symptomatology of schizophrenia while also alleviating the positive and negative symptoms associated with the illness. Conclusions: The efficacy of lurasidone in treating patients with first-episode psychosis who present with predominant depressive symptoms suggests that this medication may be a valuable treatment option not only for established cases of schizophrenia but also for individuals in the early stages of the illness. The good tolerability of lurasidone is an important factor that may positively influence treatment decisions.https://www.mdpi.com/2076-3425/14/3/225schizophreniapersonalized treatmentdepressive symptomsantipsychoticlurasidone
spellingShingle Andrea Fiorillo
Gaia Sampogna
Umberto Albert
Emi Bondi
Serafino De Giorgi
Andrea Fagiolini
Maurizio Pompili
Gianluca Serafini
Umberto Volpe
Antonio Vita
The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
Brain Sciences
schizophrenia
personalized treatment
depressive symptoms
antipsychotic
lurasidone
title The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
title_full The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
title_fullStr The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
title_full_unstemmed The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
title_short The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
title_sort role of lurasidone in managing depressive symptoms in people with schizophrenia a review
topic schizophrenia
personalized treatment
depressive symptoms
antipsychotic
lurasidone
url https://www.mdpi.com/2076-3425/14/3/225
work_keys_str_mv AT andreafiorillo theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT gaiasampogna theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT umbertoalbert theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT emibondi theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT serafinodegiorgi theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT andreafagiolini theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT mauriziopompili theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT gianlucaserafini theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT umbertovolpe theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT antoniovita theroleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT andreafiorillo roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT gaiasampogna roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT umbertoalbert roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT emibondi roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT serafinodegiorgi roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT andreafagiolini roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT mauriziopompili roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT gianlucaserafini roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT umbertovolpe roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview
AT antoniovita roleoflurasidoneinmanagingdepressivesymptomsinpeoplewithschizophreniaareview